DCT CRO company in Europe for sale

Company for sale

• • Sales: <10m EUR
  • Location: Eastern Europe, exact location will only be disclosed to seriously-interested parties
  • Reason for sale: The owners of this DCT CRO in Eastern Europe are looking for a strong parent that can drive expansion into more markets, build up digital capabilities and enlarge the team and service offering.
  • #CFIE PHS131

Overview of the DCT CRO company in Europe for sale

The company is a CRO operating in five countries of Eastern Europe. It was founded in the mid 2010’s by highly experienced health professionals and researchers. It has built a niche in DCT trials, with over 40 studies in the last few years. It has conducted some 80 Phase I-IV studies across 19 indications, with about a third involving medical devices. Growing expertise in Phase I studies. The client base includes other CROs as well as small biotech, meddev and pharma companies as well as a few global and European mid- and Big Pharma firms.

Profile (strategy) of the DCT CRO company in Europe for sale

Ongoing expansion of DCT services to additional CEE markets is the main strategic thrust for this CRO. Future plans also call for building in-house resources in data management, PV, and medical writing to expand the service portfolio. An online personnel recruitment service is quite established and could be further expanded to FSP services soon while a digital eQMS systems is in development.
The close doctor-patient relationship in CEE has allowed them to complete study recruitment very fast, thanks to its network of over 200 PIs. This close relationship is also a hallmark of the relationship with project teams at sponsors or other clients.
The company has over 100 employees, with close to half involved in DCT studies. The clinical staff consists of doctors and pharmacists qualified in various subject disciplines and has a strong track record of research.
The company has strong trial management capabilities, including study feasibility, regulatory management, vendor management and clinical trial monitoring. The company utilizes digital and cloud-based data tools and is compliant with GDPR. It has strong data capture, management, analysis and reporting capabilities.

Activities and services of the DCT CRO company in Europe for sale

The company offers clinical services for pharmaceutical and medical device studies for phase I through IV, as well as local and international clinical studies, with strong decentralized study capabilities.

Highlights of the DCT CRO company in Europe for sale

• Strong DCT focus in CEE
• Full-service CRO services, including PV, medical writing, and data management
• 100+ highly-qualified employees
• Strong PI network in several low-cost CEE countries
• Large, centralized patient pools for accelerated enrolment
• Highly competitive costs
• Modern clinical infrastructure

More information on this dCT CRO company in Europe for sale

Please get in touch if you are interested in learning more about this dCT CRO company in Europe for sale. For more cro companies for sale please visit the section cro companies for sale. For other cro buyers, please visit the section cro companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.